Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study

PURPOSE: Oxaliplatin, an important chemotherapeutic agent in colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN), for which prophylactic or therapeutic interventions are lacking. We aimed to investigate changes in upper extremities, activities of daily living (ADL), and healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Ami, Kanai, Masashi, Horimatsu, Takahiro, Tsuboyama, Tadao, Matsushima, Kanae, Kato, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982431/
https://www.ncbi.nlm.nih.gov/pubmed/29423680
http://dx.doi.org/10.1007/s00520-018-4070-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982431/
https://www.ncbi.nlm.nih.gov/pubmed/29423680
http://dx.doi.org/10.1007/s00520-018-4070-z

Ejemplares similares